ARVINAS, INC. (ARVN)
About ARVINAS, INC.
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $262.6M
- Net income
- -$80.8M
- Total assets
- $717.9M
- Market cap
- $518.1M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $518.1M
- Shares outstanding
- 71.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 27, 2018
Arvinas, Inc. (ARVN) Stock Price
- Reported a net loss of $80.8M in FY2025.
- Trading 47% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ARVINAS, INC..
Write a review
News about ARVINAS, INC.
News & sentiment via Polygon.io
Arvinas, Inc.: frequently asked questions
Is Arvinas, Inc. an American company?
Arvinas, Inc. is a US-based company headquartered in New Haven, Connecticut, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Arvinas, Inc. headquartered?
Arvinas, Inc. is headquartered in New Haven, Connecticut, United States.
Is Arvinas, Inc. publicly traded?
Yes — Arvinas, Inc. is a publicly traded company. Its stock trades under the ticker symbol ARVN on the NASDAQ.
What does Arvinas, Inc. do?
Arvinas, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
